Free Trial

Arteris, Inc. (NASDAQ:AIP) Sees Large Growth in Short Interest

Arteris logo with Computer and Technology background

Arteris, Inc. (NASDAQ:AIP - Get Free Report) saw a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 358,000 shares, a growth of 24.0% from the April 30th total of 288,600 shares. Approximately 1.3% of the shares of the company are short sold. Based on an average trading volume of 198,700 shares, the days-to-cover ratio is currently 1.8 days.

Arteris Price Performance

Shares of NASDAQ AIP traded up $0.28 during trading on Friday, hitting $7.93. The company had a trading volume of 184,190 shares, compared to its average volume of 204,528. The firm has a market capitalization of $332.89 million, a price-to-earnings ratio of -9.11 and a beta of 1.37. The stock has a fifty day simple moving average of $6.88 and a two-hundred day simple moving average of $8.59. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.30. Arteris has a fifty-two week low of $5.46 and a fifty-two week high of $12.64.

Insider Buying and Selling at Arteris

In related news, CEO K Charles Janac sold 7,150 shares of the stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $7.12, for a total transaction of $50,908.00. Following the sale, the chief executive officer now directly owns 318,117 shares of the company's stock, valued at approximately $2,264,993.04. This represents a 2.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Nicholas B. Hawkins sold 11,000 shares of the firm's stock in a transaction on Thursday, May 8th. The shares were sold at an average price of $7.54, for a total transaction of $82,940.00. Following the sale, the chief financial officer now owns 165,596 shares in the company, valued at approximately $1,248,593.84. This represents a 6.23% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 47,125 shares of company stock valued at $334,886. 29.10% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of AIP. Quarry LP purchased a new stake in Arteris during the 4th quarter worth approximately $46,000. US Bancorp DE boosted its stake in shares of Arteris by 29.0% in the fourth quarter. US Bancorp DE now owns 5,702 shares of the company's stock worth $58,000 after acquiring an additional 1,283 shares during the last quarter. CWM LLC increased its position in shares of Arteris by 4,810.1% during the first quarter. CWM LLC now owns 10,213 shares of the company's stock worth $71,000 after purchasing an additional 10,005 shares in the last quarter. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Arteris during the first quarter worth approximately $95,000. Finally, Strs Ohio acquired a new position in Arteris in the 1st quarter valued at $104,000. 64.36% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

AIP has been the subject of a number of analyst reports. Rosenblatt Securities reaffirmed a "buy" rating and issued a $14.00 price target on shares of Arteris in a report on Wednesday, May 21st. Northland Securities upped their target price on Arteris from $14.00 to $16.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 19th.

Read Our Latest Stock Report on AIP

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Articles

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines